April 01, 2022    London, UK

11th Webinar on

Otolaryngology and Rhinology

April 01, 2022   10:00 AM GMT  
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

11th Webinar on

Otolaryngology and Rhinology

Novel Technologies in Otorhinolaryngology

Briefly Know About This Event

Otolaryngology 2022 extends our immense pleasure and honour to invite you to attend the “11th Webinar on Otolaryngology and Rhinology”, scheduled on April 01, 2022. It is focusing on the theme "Novel Technologies in Otorhinolaryngology" to enhance and explore knowledge among academics and industry personnel dealing with otolaryngology and rhinology, nonmaterial and its related subjects to establish corporations and exchanging ideas and it aims to provide the right stage to present stimulating Keynote talks, plenary sessions, poster symposia, young researchers forum, video presentations.


It was found that the incidence of the ENT manifestation in COVID-19 patients is not as high as fever and cough. But, it was reported that nasal congestion (4.1%) and pharyngeal erythema (5.3%) were reported to occur in nearly similar incidence to the occurrence of diarrhea in those patients (4.2%).

  • Epidemiology
  • The SARS-CoV-2 Pandemic aspects
  • Mitigation of COVID-19
  • Virology
  • Pathophysiology and Immunopathology

Cancer of the thyroid, the butterfly-shaped gland at the base of the neck. The cause of thyroid cancer is poorly understood but may involve a combination of genetic and environmental factors. Some people have no symptoms. Others may notice a lump in the neck. Treatments, which are usually successful, include surgery, hormone therapy, radioactive iodine, radiation and in some cases chemotherapy.

  • Respiratory Papillomatosis Disease in Pregnancy
  • Treatment of Idiopathic Subglottic Stenosis 
  • Autofluorescence in Thyroid Disease
  • Glottic Cancer
  • Dysphagia/Swallowing

Two common types of chronic ear disease are chronic otitis media and cholesteatoma. Chronic otitis media is an ongoing infection or persistent fluid in the middle ear. Cholesteatoma is an abnormal growth of skin in the middle ear. Treatment for chronic ear disease depends on what is causing your child's symptoms.

  • Eustachian Tube Dysfunction
  • Epithelial Migration
  • Pathophysiology of Cholesteatoma
  • Microbiology of Chronic Ear Disease
  • Autoimmune Disease
  • Skull Base Osteomyelitis
  • Hearing Rehabilitation
  • Facial Neuropathy

ENT surgery has a variety of major and minor surgeries including laser and endoscopic surgeries performed under both local anesthesias with sedation (MAC- Monitored anesthesia care), general anesthesia (with endotracheal intubation or LMA- Laryngeal mask airway) and TIVA (Total intravenous anesthesia).

  • Anesthesia for ENT laser Surgery
  • Anesthesia for nasal, sinus and pituitary surgery
  • Anesthesia for endoscopic sinus surgery
  • Head and neck flap reconstructive surgery

Otolaryngologists assessed that wheezing happens in 3 to 12% of youngsters and up to 59% of grown-ups. Wheezing is interrelated to obstructive rest apnea (OSA). OSA is a genuine rest issue and it impacts shallow or may even quit breathing during rest. There are numerous kinds of rest apnea, however the principal influencing apnea is obstructive rest apnea. The significant reasons for OSA is abundance weight, limited aviation route, hypertension and ceaseless nasal clog. Uvulopalatopharyngoplasty (UPPP) is a sort of ENT medical procedure which is the most widely recognized kind of medical procedure for OSA.

  • Sleep Disorders
  • Upper Airway Imaging
  • Upper Airway Resistance Syndrome (UARS)
  • Neurologic Disorders
  • Medication Effects

Our Brilliant Speakers

LONGDOM conferences speaker bureau map future challenges through ideation sessions by designing and validating new ideas with end users by placing right speakers in front of right audience at the right time.

What Client's Say

We let our ground-breaking work and our amazing clients speak for us…… LONGDOM conferences

  [email protected]
  [email protected]
  [email protected]
Speakers Interview